Shares of Acadia Healthcare Co. (NASDAQ:ACHC) were down 5.1% on Wednesday . The stock traded as low as $51.29 and last traded at $51.38, with a volume of 977,632 shares trading hands. The stock had previously closed at $54.13.

Several analysts have recently weighed in on ACHC shares. Zacks Investment Research upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research note on Tuesday, April 19th. Mizuho lifted their price objective on shares of Acadia Healthcare from $66.00 to $71.00 and gave the company a “buy” rating in a research note on Friday, April 29th. Cantor Fitzgerald reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Friday, April 29th. Leerink Swann reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Monday, May 2nd. Finally, Jefferies Group reiterated a “buy” rating and issued a $85.00 price objective on shares of Acadia Healthcare in a research note on Thursday, May 5th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $79.33.

The stock has a 50-day moving average price of $56.49 and a 200-day moving average price of $57.18. The stock has a market cap of $4.48 billion and a PE ratio of 30.49.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Thursday, April 28th. The company reported $0.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.01. During the same period in the previous year, the business posted $0.43 earnings per share. The firm earned $616.80 million during the quarter, compared to analysts’ expectations of $612.77 million. The company’s revenue for the quarter was up 68.6% on a year-over-year basis. On average, analysts anticipate that Acadia Healthcare Co. will post $2.82 earnings per share for the current fiscal year.

Several hedge funds and institutional investors recently bought and sold shares of ACHC. State Board of Administration of Florida Retirement System increased its position in Acadia Healthcare by 8.5% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 33,247 shares of the company’s stock valued at $2,077,000 after buying an additional 2,596 shares during the period. Rhumbline Advisers increased its position in Acadia Healthcare by 6.1% in the fourth quarter. Rhumbline Advisers now owns 53,198 shares of the company’s stock valued at $3,323,000 after buying an additional 3,045 shares during the period. California Public Employees Retirement System increased its position in Acadia Healthcare by 0.9% in the fourth quarter. California Public Employees Retirement System now owns 82,700 shares of the company’s stock valued at $5,165,000 after buying an additional 700 shares during the period. New York State Common Retirement Fund increased its position in Acadia Healthcare by 11.3% in the fourth quarter. New York State Common Retirement Fund now owns 190,543 shares of the company’s stock valued at $11,901,000 after buying an additional 19,337 shares during the period. Finally, Mutual of America Capital Management LLC increased its position in Acadia Healthcare by 0.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 57,344 shares of the company’s stock valued at $3,582,000 after buying an additional 194 shares during the period.

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.